vs
Amalgamated Financial Corp.（AMAL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Amalgamated Financial Corp.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$85.2M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 9.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 4.3%）
CI金融集团是一家总部位于加拿大安大略省多伦多的投资管理公司，面向高净值个人投资者提供投资管理与财富管理服务，同时也为投资组合经理及机构投资者提供经纪与交易服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMAL vs RIGL — 直观对比
营收规模更大
AMAL
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出11.8%
9.4%
两年增速更快
RIGL
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $85.2M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 39.0% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 9.4% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.88 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMALRIGL
| Q4 25 | $85.2M | $69.8M | ||
| Q3 25 | $85.6M | $69.5M | ||
| Q2 25 | $80.9M | $101.7M | ||
| Q1 25 | $77.0M | $53.3M | ||
| Q4 24 | $77.9M | $57.6M | ||
| Q3 24 | $81.0M | $55.3M | ||
| Q2 24 | $78.5M | $36.8M | ||
| Q1 24 | $78.3M | $29.5M |
净利润AMALRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $26.8M | $27.9M | ||
| Q2 25 | $26.0M | $59.6M | ||
| Q1 25 | $25.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $27.9M | $12.4M | ||
| Q2 24 | $26.8M | $-1.0M | ||
| Q1 24 | $27.2M | $-8.2M |
毛利率AMALRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率AMALRIGL
| Q4 25 | 39.0% | 33.2% | ||
| Q3 25 | 42.9% | 40.9% | ||
| Q2 25 | 43.8% | 60.1% | ||
| Q1 25 | 45.1% | 23.9% | ||
| Q4 24 | 42.4% | 28.9% | ||
| Q3 24 | 47.2% | 25.4% | ||
| Q2 24 | 45.6% | 1.2% | ||
| Q1 24 | 49.2% | -23.6% |
净利率AMALRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 31.3% | 40.2% | ||
| Q2 25 | 32.1% | 58.6% | ||
| Q1 25 | 32.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 34.5% | 22.5% | ||
| Q2 24 | 34.1% | -2.8% | ||
| Q1 24 | 34.8% | -27.9% |
每股收益（稀释后）AMALRIGL
| Q4 25 | $0.88 | $14.11 | ||
| Q3 25 | $0.88 | $1.46 | ||
| Q2 25 | $0.84 | $3.28 | ||
| Q1 25 | $0.81 | $0.63 | ||
| Q4 24 | $0.78 | $0.82 | ||
| Q3 24 | $0.90 | $0.70 | ||
| Q2 24 | $0.87 | $-0.06 | ||
| Q1 24 | $0.89 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $291.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $794.5M | $391.5M |
| 总资产 | $8.9B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMALRIGL
| Q4 25 | $291.2M | $155.0M | ||
| Q3 25 | $115.5M | $137.1M | ||
| Q2 25 | $171.1M | $108.4M | ||
| Q1 25 | $65.7M | $77.1M | ||
| Q4 24 | $60.7M | $77.3M | ||
| Q3 24 | $149.2M | $61.1M | ||
| Q2 24 | $58.0M | $49.1M | ||
| Q1 24 | $155.2M | $49.5M |
总债务AMALRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMALRIGL
| Q4 25 | $794.5M | $391.5M | ||
| Q3 25 | $775.6M | $117.6M | ||
| Q2 25 | $754.0M | $81.9M | ||
| Q1 25 | $736.0M | $18.6M | ||
| Q4 24 | $707.7M | $3.3M | ||
| Q3 24 | $698.2M | $-14.6M | ||
| Q2 24 | $646.0M | $-29.9M | ||
| Q1 24 | $616.8M | $-31.7M |
总资产AMALRIGL
| Q4 25 | $8.9B | $513.6M | ||
| Q3 25 | $8.7B | $242.5M | ||
| Q2 25 | $8.6B | $206.7M | ||
| Q1 25 | $8.3B | $176.0M | ||
| Q4 24 | $8.3B | $164.0M | ||
| Q3 24 | $8.4B | $139.4M | ||
| Q2 24 | $8.3B | $128.4M | ||
| Q1 24 | $8.1B | $126.5M |
负债/权益比AMALRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $135.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $134.4M | — |
| 自由现金流率自由现金流/营收 | 157.8% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $229.4M | — |
8季度趋势，按日历期对齐
经营现金流AMALRIGL
| Q4 25 | $135.8M | $22.0M | ||
| Q3 25 | $39.5M | $24.0M | ||
| Q2 25 | $24.9M | $30.5M | ||
| Q1 25 | $34.2M | $-893.0K | ||
| Q4 24 | $124.1M | $14.5M | ||
| Q3 24 | $35.8M | $21.7M | ||
| Q2 24 | $28.0M | $302.0K | ||
| Q1 24 | $31.3M | $-5.0M |
自由现金流AMALRIGL
| Q4 25 | $134.4M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $24.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | $122.3M | — | ||
| Q3 24 | $35.2M | — | ||
| Q2 24 | $27.8M | — | ||
| Q1 24 | $31.1M | — |
自由现金流率AMALRIGL
| Q4 25 | 157.8% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 29.9% | — | ||
| Q1 25 | 42.2% | — | ||
| Q4 24 | 157.0% | — | ||
| Q3 24 | 43.4% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 39.7% | — |
资本支出强度AMALRIGL
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率AMALRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.47× | 0.86× | ||
| Q2 25 | 0.96× | 0.51× | ||
| Q1 25 | 1.37× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.28× | 1.75× | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
